Noncoding RNA and Molecular Mechanisms of Metastasis in Gastrointestinal Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 3
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gastrointestinal cancers, including colorectal and gastric cancers, remain leading causes of global cancer-related mortality, with metastasis being the primary driver of poor prognosis. Noncoding RNAs (ncRNAs), such as microRNAs, long ncRNAs, and circular RNAs, have emerged as critical regulators of metastasis-related molecular pathways—yet their specific roles in gastrointestinal cancer metastasis (e.g., epithelial–mesenchymal transition and angiogenesis) remain incompletely elucidated, leaving gaps in translational research.
This Special Issue aims to compile cutting-edge studies that advance understanding of ncRNA-mediated mechanisms in gastrointestinal cancer metastasis, ensuring alignment with the journal’s focus on cancer biology and molecular therapeutics. We target at least 10 articles to potentially form a printed book, welcoming original research (e.g., in vitro/in vivo ncRNA function studies) and reviews (e.g., systematic analyses of ncRNA biomarkers).
Research areas include (but not limited to) the following: ncRNA regulation of metastasis signaling pathways, ncRNA-based diagnostic/prognostic markers, and ncRNA-targeted therapeutic strategies for gastrointestinal cancers.
Prof. Dr. Kaihong Huang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- noncoding RNA
- gastrointestinal cancers
- metastasis
- molecular mechanisms
- microRNA
- long noncoding RNA
- circular RNA
- cancer biology
- biomarkers
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
